| Announce Date | 10/27/2025 |
| EPS Normalized Actual | $-0.19 (Beat by $0.19) |
| EPS GAAP Actual | $-0.19 (Beat by $0.19) |
| Revenue Actual | $0.257187B |
| Revenue Surprise | Beat by $257.187M |
| Announce Date | 12/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $-0.44 |
| EPS GAAP Estimate | $-0.44 |
| Revenue Estimate | $0.268730743B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | -0.43 | -17.76 | -0.50686 | -0.39371 | 3 |
| Dec 2027 | -0.525 | -14.54 | -0.61884 | -0.48069 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.07 | -0.07 | 0.257187B | -21.09% | 257.19M |
| FQ2 2025 (Jun 2025) | -0.34 | -0.34 | 0.282251B | -41.05% | 282.25M |
| FQ2 2024 (Jun 2024) | -0.93 | -0.93 | 0.398104B | 100% | 398.1M |
| FQ3 2024 (Sep 2024) | -1.33 | -1.33 | 0.311428B | 100% | 311.43M |
| FQ4 2024 (Dec 2024) | -1.66 | -1.66 | 0.303151B | 100% | 303.15M |
| FQ1 2025 (Mar 2025) | -0.74 | -0.74 | 0.231748B | 100% | 231.75M |
| FQ1 2023 (Feb 2023) | 0 | 0 | 1.18514B | 100% | 1185.14M |
| FQ4 2022 (Nov 2022) | -4.33 | -4.33 | 1.25911B | 100% | 1259.11M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.44
Consensus Revenue Estimates
0.268730743B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | 0 | -- | 0 | 0 | 1 |
| FQ3 2027 (Aug 2027) | 0 | -- | 0 | 0 | 2 |
| FQ2 2027 (May 2027) | 0 | -- | 0 | 0 | 2 |
| FQ1 2027 (Feb 2027) | 0 | -- | 0 | 0 | 1 |
| FQ4 2026 (Nov 2026) | -0.19 | -- | -0.19749 | -0.17401 | 1 |
| FQ3 2026 (Aug 2026) | -0.21 | 66.67 | -0.21827 | -0.19233 | 2 |
| FQ2 2026 (May 2026) | -0.14 | -142.86 | -0.14552 | -0.12822 | 2 |
| FQ1 2026 (Feb 2026) | -0.15 | -393.33 | -0.15591 | -0.13738 | 1 |
| FQ4 2025 (Dec 2025) | -0.44 | -277.27 | -0.64308 | -0.28769 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | 0.42B | -- | 0.4B | 0.44B | 2 |
| FQ3 2027 (Aug 2027) | 0.46B | -- | 0.43B | 0.47B | 2 |
| FQ2 2027 (May 2027) | 0.47B | -- | 0.44B | 0.49B | 2 |
| FQ1 2027 (Feb 2027) | 0.39B | -- | 0.36B | 0.4B | 3 |
| FQ4 2026 (Nov 2026) | 0.31B | -- | 0.29B | 0.32B | 2 |
| FQ3 2026 (Aug 2026) | 0.29B | 11.85 | 0.27B | 0.3B | 2 |
| FQ2 2026 (May 2026) | 0.32B | 12.32 | 0.3B | 0.33B | 2 |
| FQ1 2026 (Feb 2026) | 0.27B | 13.52 | 0.25B | 0.28B | 3 |
| FQ4 2025 (Dec 2025) | 0.27B | -12.81 | 0.25B | 0.28B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
7
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.07 | -0.07 | 100% | |
| FQ2 2025 (Jun 2025) | -0.34 | -0.34 | 100% | |
| FQ2 2024 (Jun 2024) | -0.93 | -0.93 | 100% | |
| FQ3 2024 (Sep 2024) | -1.33 | -1.33 | 100% | |
| FQ4 2024 (Dec 2024) | -1.66 | -1.66 | 100% | |
| FQ1 2025 (Mar 2025) | -0.74 | -0.74 | 100% | |
| FQ1 2023 (Feb 2023) | 0 | 0 | NAN% | |
| FQ4 2022 (Nov 2022) | -4.33 | -4.33 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.26B | $257.19M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.28B | $282.25M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.4B | $398.1M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.31B | $311.43M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.3B | $303.15M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.23B | $231.75M | 100% |
| FQ1 2023 (Feb 2023) | $0B | $1.19B | $1185.14M | 100% |
| FQ4 2022 (Nov 2022) | $0B | $1.26B | $1259.11M | 100% |